214 related articles for article (PubMed ID: 21259444)
21. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationship studies of 1-substituted 3-dodecanoylindole-2-carboxylic acids as inhibitors of cytosolic phospholipase A2-mediated arachidonic acid release in intact platelets.
Griessbach K; Klimt M; Schulze Elfringhoff A; Lehr M
Arch Pharm (Weinheim); 2002; 335(11-12):547-55. PubMed ID: 12596219
[TBL] [Abstract][Full Text] [Related]
23. Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.
Gustin DJ; Ma Z; Min X; Li Y; Hedberg C; Guimaraes C; Porter AC; Lindstrom M; Lester-Zeiner D; Xu G; Carlson TJ; Xiao S; Meleza C; Connors R; Wang Z; Kayser F
Bioorg Med Chem Lett; 2011 Apr; 21(8):2492-6. PubMed ID: 21392988
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency.
Tian G; Paschetto KA; Gharahdaghi F; Gordon E; Wilkins DE; Luo X; Scott CW
Biochemistry; 2011 Aug; 50(32):6867-78. PubMed ID: 21728345
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, activity, metabolic stability and cell permeability of new cytosolic phospholipase A
Subeska A; Voundi ME; Hanekamp W; Mulac D; Langer K; Lehr M
Bioorg Med Chem Lett; 2023 Aug; 92():129374. PubMed ID: 37315699
[TBL] [Abstract][Full Text] [Related]
26. Chemistry around imidazopyrazine and ibuprofen: discovery of novel fatty acid amide hydrolase (FAAH) inhibitors.
De Wael F; Muccioli GG; Lambert DM; Sergent T; Schneider YJ; Rees JF; Marchand-Brynaert J
Eur J Med Chem; 2010 Sep; 45(9):3564-74. PubMed ID: 20570023
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
Morera L; Labar G; Ortar G; Lambert DM
Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
[TBL] [Abstract][Full Text] [Related]
28. A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.
Gattinoni S; Simone CD; Dallavalle S; Fezza F; Nannei R; Battista N; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
Bioorg Med Chem Lett; 2010 Aug; 20(15):4406-11. PubMed ID: 20591666
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationship studies on 1-(5-carboxyindol-1-yl)-propan-2-one inhibitors of human cytosolic phospholipase A2α: variation of the activated ketone moiety.
Kaptur M; Elfringhoff AS; Lehr M
Bioorg Med Chem Lett; 2011 Mar; 21(6):1773-6. PubMed ID: 21316224
[TBL] [Abstract][Full Text] [Related]
30. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Walker MC; Schweitzer BA; Madsen HM; Tenbrink RE; McDonald J; Smith SE; Foltin S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6538-44. PubMed ID: 21924614
[TBL] [Abstract][Full Text] [Related]
32. Convergent and enantioselective syntheses of cytosolic phospholipase A(2)α inhibiting N-(1-indazol-1-ylpropan-2-yl)carbamates.
Sundermann T; Arnsmann M; Schwarzkopf J; Hanekamp W; Lehr M
Org Biomol Chem; 2014 Jun; 12(23):4021-30. PubMed ID: 24817191
[TBL] [Abstract][Full Text] [Related]
33. [Carboxyl-
Fisher MJ; McMurray L; Lu S; Morse CL; Liow JS; Zoghbi SS; Kowalski A; Tye GL; Innis RB; Aigbirhio FI; Pike VW
ChemMedChem; 2018 Jan; 13(2):138-146. PubMed ID: 29232493
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid.
Petit S; Duroc Y; Larue V; Giglione C; Léon C; Soulama C; Denis A; Dardel F; Meinnel T; Artaud I
ChemMedChem; 2009 Feb; 4(2):261-75. PubMed ID: 19053131
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, biological evaluation, and structure-activity relationships of 3-acylindole-2-carboxylic acids as inhibitors of the cytosolic phospholipase A2.
Lehr M
J Med Chem; 1997 Aug; 40(17):2694-705. PubMed ID: 9276015
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and
Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
[TBL] [Abstract][Full Text] [Related]
38. Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors.
Ramarao MK; Shen MW; Murphy EA; Duan W; Zhao Y; McKew J; Lee KL; Thakker P; Behnke ML; Clark JD
Anal Biochem; 2008 Dec; 383(2):217-25. PubMed ID: 18801329
[TBL] [Abstract][Full Text] [Related]
39. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
Seierstad M; Breitenbucher JG
J Med Chem; 2008 Dec; 51(23):7327-43. PubMed ID: 18983142
[No Abstract] [Full Text] [Related]
40. Benzhydrylquinazolinediones: novel cytosolic phospholipase A2alpha inhibitors with improved physicochemical properties.
Kirincich SJ; Xiang J; Green N; Tam S; Yang HY; Shim J; Shen MW; Clark JD; McKew JC
Bioorg Med Chem; 2009 Jul; 17(13):4383-405. PubMed ID: 19482480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
